![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, April 12, 2020 4:12:25 PM
1.) CCR5 makes cancers cells metastasize ...
........A.) By calcium channel signalling on CCR5 on cancer cells , witch is important to produce metastasis.
........B.) CCR5 makes tumors more aggressive , CCR5 center cells cluster together in a different way witch enables the cancer cells to metastasize ...(Thank you Trding).
.........C. ) once cancer cells enter to bloodstream and ( and thus become ) CTC, being CCR5 + guides them to the most dangerous and deadly possible sites : Brain , bones , other organs , ..(.Thank you Trding.)
Leronlimab block all this...
Papers:
https://content.equisolve.net/_5dde3bf0adc368...breast.pdf
https://content.equisolve.net/_5dde3bf0adc368...review.pdf
https://content.equisolve.net/_5dde3bf0adc368...ostate.pdf
https://cancerres.aacrjournals.org/content/ca...7.full.pdf
2.) CCR5 activates DNA mechanism....
...........cancer cells recuperate much faster after chemotherapy , becoming resistant to treatment ,
Leronlimab is blocking that.
Papers:
https://content.equisolve.net/_5dde3bf0adc368...R.full.pdf
https://www.cell.com/stem-cell-reports/pdf/S2...0145-6.pdf
3.) Regulate body anti-tumor response ..
...........A. ) there is polarization of macrophages with CCR5 inhibitors.
process by witch macrophages adopt different functional programs..
M0--uncommitted macrophages ..
M1--classically activated , produce pro-inflammatory process and irritation of immune system , important in the host defense against pathogens .
M2--alternatively activated, turning on constructive process, like wound healing , producing anti-inflammatory cytokines.
And all this help to produce necrosis of tumors.
............B. ) From Dr Patterson we also know that CCR5 is expressed on the population of immune cells call T regulatory cells witch inhibits response to cancers .
Papers:
https://www.cell.com/cancer-cell/pdf/S1535-61...0102-7.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC...-01477.pdf
https://www.frontiersin.org/articles/10.3389/...02629/full
4.) Leronlimab inhibits angiogenesis
Recently we also learned from Dr Lindner pre-clinical study in colon cancer that Leronlimab inhibits angiogenesis , and is working on solid tumors with both high and low CCR5 expression..
Papers:
https://www.ncbi.nlm.nih.gov/pubmed/25330803
https://academic.oup.com/carcin/article/36/1/104/376718
https://www.cell.com/stem-cell-reports/pdf/S2...0145-6.pdf
https://www.cytodyn.com/newsroom/press-releas...of-ccr5-in
5) CCR5 Promotes Cancer Recurrance
Paper:
https://elifesciences.org/articles/43653
Node-Negative Overall Survival with ccr5 from Pestell paper Figure 1B
https://content.equisolve.net/_5dde3bf0adc368...R.full.pdf
1445403104_nodeneg.jpg
Chump
Recent CYDY News
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/22/2024 01:00:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:17:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:16:28 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM